TRUEBLUE INC (TBI) Stock Fundamental Analysis

NYSE:TBI • US89785X1019

3.71 USD
-0.2 (-5.12%)
Last: Feb 20, 2026, 08:06 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, TBI scores 3 out of 10 in our fundamental rating. TBI was compared to 88 industry peers in the Professional Services industry. While TBI seems to be doing ok healthwise, there are quite some concerns on its profitability. TBI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year TBI has reported negative net income.
  • In the past year TBI has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: TBI reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: TBI reported negative operating cash flow in multiple years.
TBI Yearly Net Income VS EBIT VS OCF VS FCFTBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • TBI has a worse Return On Assets (-4.07%) than 67.05% of its industry peers.
  • The Return On Equity of TBI (-9.24%) is worse than 65.91% of its industry peers.
Industry RankSector Rank
ROA -4.07%
ROE -9.24%
ROIC N/A
ROA(3y)-4.7%
ROA(5y)-4.52%
ROE(3y)-10.14%
ROE(5y)-10.07%
ROIC(3y)N/A
ROIC(5y)N/A
TBI Yearly ROA, ROE, ROICTBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • TBI has a Gross Margin of 24.02%. This is in the lower half of the industry: TBI underperforms 67.05% of its industry peers.
  • In the last couple of years the Gross Margin of TBI has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for TBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y-0.39%
TBI Yearly Profit, Operating, Gross MarginsTBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • TBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for TBI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TBI Yearly Shares OutstandingTBI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TBI Yearly Total Debt VS Total AssetsTBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • TBI has an Altman-Z score of 3.26. This indicates that TBI is financially healthy and has little risk of bankruptcy at the moment.
  • TBI's Altman-Z score of 3.26 is fine compared to the rest of the industry. TBI outperforms 64.77% of its industry peers.
  • TBI has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of TBI (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 3.26
ROIC/WACCN/A
WACC9.15%
TBI Yearly LT Debt VS Equity VS FCFTBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • TBI has a Current Ratio of 2.01. This indicates that TBI is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of TBI (2.01) is better than 73.86% of its industry peers.
  • A Quick Ratio of 2.01 indicates that TBI has no problem at all paying its short term obligations.
  • The Quick ratio of TBI (2.01) is better than 76.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 2.01
TBI Yearly Current Assets VS Current LiabilitesTBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for TBI have decreased strongly by -53.33% in the last year.
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1150%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 81.33% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y138.55%
EPS Next 2Y81.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y3.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

TBI Yearly Revenue VS EstimatesTBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
TBI Yearly EPS VS EstimatesTBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TBI. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 13.95, which indicates a correct valuation of TBI.
  • Based on the Price/Forward Earnings ratio, TBI is valued a bit cheaper than 61.36% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of TBI to the average of the S&P500 Index (28.06), we can say TBI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 13.95
TBI Price Earnings VS Forward Price EarningsTBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TBI Per share dataTBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • TBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TBI's earnings are expected to grow with 81.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.33%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TBI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRUEBLUE INC

NYSE:TBI (2/20/2026, 8:06:46 PM)

3.71

-0.2 (-5.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-18
Earnings (Next)05-04
Inst Owners98.47%
Inst Owner Change-2.91%
Ins Owners4.75%
Ins Owner Change-0.59%
Market Cap111.08M
Revenue(TTM)N/A
Net Income(TTM)-28.13M
Analysts80
Price Target8.67 (133.69%)
Short Float %5.81%
Short Ratio8.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)82.46%
Min EPS beat(2)28.92%
Max EPS beat(2)136%
EPS beat(4)3
Avg EPS beat(4)57%
Min EPS beat(4)-24.74%
Max EPS beat(4)136%
EPS beat(8)6
Avg EPS beat(8)53.54%
EPS beat(12)8
Avg EPS beat(12)35.65%
EPS beat(16)11
Avg EPS beat(16)35.09%
Revenue beat(2)1
Avg Revenue beat(2)1.18%
Min Revenue beat(2)-2.04%
Max Revenue beat(2)4.4%
Revenue beat(4)2
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-2.04%
Max Revenue beat(4)4.4%
Revenue beat(8)3
Avg Revenue beat(8)-0.22%
Revenue beat(12)3
Avg Revenue beat(12)-1.16%
Revenue beat(16)5
Avg Revenue beat(16)-0.62%
PT rev (1m)0%
PT rev (3m)-1.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-966.6%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.95
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)0.27
Fwd EY7.17%
FCF(TTM)-2.18
FCFYN/A
OCF(TTM)-1.59
OCFYN/A
SpS52.9
BVpS10.16
TBVpS8.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -9.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.02%
FCFM N/A
ROA(3y)-4.7%
ROA(5y)-4.52%
ROE(3y)-10.14%
ROE(5y)-10.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y-0.39%
F-Score3
Asset Turnover2.29
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.33%
Cap/Sales 1.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 2.01
Altman-Z 3.26
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)102.48%
Cap/Depr(5y)103.83%
Cap/Sales(3y)1.51%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1150%
EPS Next Y138.55%
EPS Next 2Y81.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.35%
Revenue Next Year5.04%
Revenue Next 2Y3.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.91%
EBIT Next 3Y37.45%
EBIT Next 5YN/A
FCF growth 1Y-325.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-179.24%
OCF growth 3YN/A
OCF growth 5YN/A

TRUEBLUE INC / TBI FAQ

Can you provide the ChartMill fundamental rating for TRUEBLUE INC?

ChartMill assigns a fundamental rating of 3 / 10 to TBI.


What is the valuation status of TRUEBLUE INC (TBI) stock?

ChartMill assigns a valuation rating of 4 / 10 to TRUEBLUE INC (TBI). This can be considered as Fairly Valued.


What is the profitability of TBI stock?

TRUEBLUE INC (TBI) has a profitability rating of 1 / 10.


What is the financial health of TRUEBLUE INC (TBI) stock?

The financial health rating of TRUEBLUE INC (TBI) is 5 / 10.